257 results on '"Klumpp, Bernhard"'
Search Results
2. Early Tumor Size Reduction of at least 10% at the First Follow-Up Computed Tomography Can Predict Survival in the Setting of Advanced Melanoma and Immunotherapy
3. Diagnostic Imaging of Peritoneal Tumors
4. Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?
5. S2k‐Leitlinie – Merkelzellkarzinom – Update 2022
6. S2k Guideline – Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – Update 2022
7. Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
8. S2k Guideline : Merkel cell carcinoma
9. Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen
10. Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study
11. Complete response of merkel cell carcinoma with brain metastases to pembrolizumab and radiotherapy: A case report
12. Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study
13. Entwicklung einer Prüfmethode
14. Anwendung des Verfahrens in realen Einsatzfällen
15. Literatur
16. Ableitung von Entwicklungschwerpunkten
17. Konzeption und Realisierung einer Prüfeinrichtung zur Beurteilung der Partikelreinheit technischer Oberflächen
18. Stand der Technik
19. Analyse der Randbedingungen zur Prüfung der Partikelreinheit technischer Oberflächen
20. Fusion of MR coronary angiography and viability imaging: Feasibility and clinical value for the assignment of myocardial infarctions
21. Zusammenfassung und Ausblick
22. Cardiac magnetic resonance imaging in patients undergoing percutaneous mitral valve repair with the MitraClip system
23. Low-Dose, Time-Resolved, Contrast-Enhanced 3D MR Angiography in the Assessment of the Abdominal Aorta and Its Major Branches at 3 Tesla
24. Determination of Unknown High-Grade Atherosclerotic Lesions by Whole-Body Cardiovascular Imaging: Assessment of Patients with Symptomatic Atherosclerotic Disease of Peripheral Arteries
25. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI
26. Early Tumor Size Reduction of at least 10% at the First Follow-Up Computed Tomography Can Predict Survival in the Setting of Advanced Melanoma and Immunotherapy
27. Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings
28. Late enhancement using multidetector row computer tomography: A feasibility study with low dose 80 kV protocol
29. Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography
30. High resolution myocardial magnetic resonance stress perfusion imaging at 3 T using a 1 M contrast agent
31. Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T
32. Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease
33. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
34. A comprehensive approach to the analysis of contrast enhanced cardiac MR images
35. Einleitung
36. CT texture analysis compared to Positron Emission Tomography (PET) and mutational status in resected melanoma metastases
37. Performance of two Methods for Cardiac MRI Edema Mapping: Dual-Contrast Fast Spin-Echo and T2 Prepared Balanced Steady State Free Precession
38. MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
39. Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy
40. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up
41. Additional file 3: of Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma â results of a prospective biomarker study
42. Additional file 1: of Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma â results of a prospective biomarker study
43. Additional file 2: of Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma â results of a prospective biomarker study
44. Quantitative assessment of ventricular function using three-dimensional SSFP magnetic resonance angiography
45. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up
46. S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis
47. S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018
48. S2k‐Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) – Update 2018
49. Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis
50. S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.